Basit öğe kaydını göster

The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis.

dc.contributor.authorYILMAZ, C
dc.contributor.authorHINDILERDEN, Fehmi
dc.contributor.authorAKADAM-TEKER, B
dc.contributor.authorNALCACI, Meliha
dc.contributor.authorDaglar-Aday, Aynur
dc.contributor.authorYAVUZ, AS
dc.contributor.authorSARGIN, D
dc.contributor.authorYONAL-HINDILERDEN, I
dc.date.accessioned2021-03-04T08:03:50Z
dc.date.available2021-03-04T08:03:50Z
dc.identifier.citationYONAL-HINDILERDEN I., Daglar-Aday A., HINDILERDEN F., AKADAM-TEKER B., YILMAZ C., NALCACI M., YAVUZ A., SARGIN D., "The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis.", Journal of clinical medicine research, cilt.8, ss.29-39, 2016
dc.identifier.othervv_1032021
dc.identifier.otherav_615e10e4-faa9-4da7-b412-a4110cc0762c
dc.identifier.urihttp://hdl.handle.net/20.500.12627/67885
dc.identifier.urihttps://doi.org/10.14740/jocmr2405w
dc.language.isoeng
dc.titleThe Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis.
dc.typeMakale
dc.relation.journalJournal of clinical medicine research
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume8
dc.identifier.startpage29
dc.identifier.endpage39
dc.contributor.firstauthorID178757


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster